Psychiatr. pro Praxi, 2004; 6: 304-308

Medikamentózne ovplyvnenie cravingu

MUDr. Jela Hrnčiarová
OLÚP Predná Hora, CPLDZ

Keywords: alcohol craving, cocaine craving, opiates craving, nicotine craving.

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrnčiarová J. Medikamentózne ovplyvnenie cravingu. Psychiatr. praxi. 2004;9(6):304-308.

Článok sa sústreďuje na medikamentózne ovplyvnenie cravingu vyvolaného rôznymi psychoaktívnymi látkami. Zistenia sú doložené animálnymi a humánnymi štúdiami.

Kľúčové slová

Alkoholový craving, kokaínový craving, opiátový craving, nikotínový craving.

Pharmacological influence on craving

Articles focuses on pharmacological influence on craving evoked by different psychoactive drugs. Results are evidenced with animal and human studies.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aigner T, Weiss SRB, Post RM. Carbamazepine attenuates i.v.cocaine self-administration in rhesus monkeys. Abstract, 1990, ACNP 181.
    2. Anton R, Moak D, Latham P, Waid LR, Malcolm RJ, Dias JK. Naltrexone and cognitive behavioral therapy for the treatment of autpatient alcoholics: results of a placebo-controlled trial. American Journal of Psychiatry, 1999; 156: 1758-1764. Go to original source... Go to PubMed...
    3. Balldin J, Berggren U, Engel J, Erikson M, Hard E, Soderpalm B. Effect of citalopram on alcohol intake in heavy drinkers. Alcohol Clin. Exp. Res., 1994; 18, 6: 133-136. Go to original source... Go to PubMed...
    4. Berger SP. Haloperidol antagonism of cue-elicited cocaine craving. Lancet, 1996; 347: 504-508. Go to original source... Go to PubMed...
    5. Bielajew C, Bushnik T, Konkle ATM, Parkin E. Control of motor seizures by brotizolam with maintenance of stable refractory periods for self-stimulation. Physiology and Behavior, 1999; 67: 235-241. Go to original source... Go to PubMed...
    6. Borg V. Bromocriptine in the prevention of alcohol abuse. Acta. Psychiatr. Scand., 1983; 69: 100-110. Go to original source... Go to PubMed...
    7. Bruno F. Buspirone in the treatment of alcoholic patients. Psychopathology, 1989; 22: 49-59. Go to original source... Go to PubMed...
    8. Catafau AM, Etcheberrigaray A, Perez de los Cobos J, Estorch M, Guardia J, Flotats A, Berna L, Mari C, Casas M, Carrio I. Regional cerebral blood flow changes in chronic alcoholic patients induced by naltrexon challenge durin detoxifikation. J. Nucl. Med., 1999; 40: 19-24. Go to PubMed...
    9. Collins D, Myers R. Buspirone attenuates volitional alcohol intake in the chronically drinking monkey. Alcohol, 1987; 4: 456. Go to original source... Go to PubMed...
    10. Covi L, Hess JM, Schroeder JR, Preston KL. A dose response study of cognitive behavioral therapy in cocaine abusers. Journal od Substance Abuse Treatment, 2002; 23, 3: 191-197. Go to original source... Go to PubMed...
    11. Dobrovitsky V, Pimentel P, Duarte A, Froestl W, Stellar JR, Trzcinska M. CGP 44532, a GABA-B receptor agonist, is hedonically neutral and reduces cocaine-induced enhancement of reward. Neuropharmacology, 2002; 42, 5: 626-632. Go to original source... Go to PubMed...
    12. Durcan MJ, Deener G, White J, Johnston A, Gonzales D, Niaura R, Rigotti N, Sachs DLP. The effect of bupropion sustained-release on cigarette craving after smoking cessation. Clinical Therapeutics, 2002; 24, 4: 540-551. Go to original source... Go to PubMed...
    13. Froehlich JC, Li TK. Opioid involvement in alcohol drinking. Ann NY Acad Sci, 1994; 739: 156-167. Go to original source... Go to PubMed...
    14. Geerlings PJ, Ansons C, van den Brink W. Acamprosate and prevention of relkapse in alcoholics. Eur.Addict. Res., 1997; 3: 129-137. Go to original source...
    15. Gerrits MAFM, Van Ree JM. Endorphins and experimental drug addiction. European Neuropsychopharmacology, 1996; 6 (Suppl. 4): S4. Go to original source...
    16. Goeders NE, McNulty MA, Mirkis S, McAllister KH. Chlordiazepoxide alters intravenous cocaine self-administration in rats. Pharmacology, Biochemistry and Behavior, 1989; 33: 859-866. Go to original source... Go to PubMed...
    17. Goudreau JL, Wagner EJ, Lookingland KJ, Moore KE. ?-Aminobutyric acid receptor-mediated regulation of periventricular-hypophysial dopaminergic neurons: Possible role in mediating stress- and 5-hydroxytryptamine-induced decreases in neuronal activity. Journal of Pharmacology and Experimental Therapeutics, 1994; 271: 1000-1006.
    18. Gray JA. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts. Drug and Alcohol Dependence, 1995; 39, 3: 207-212. Go to original source... Go to PubMed...
    19. Greenwald M. Heroin craving and drug use in opioid-maintained volunteers. Effects of methadone dose variations. Experimental and Clinical Psychopharmacology, 2002; 10, 1: 39-46. Go to original source... Go to PubMed...
    20. Hammoumi S, Naassila M, Daoust M. Experimental findings in the study of the reduction of alcohol intake. Eur. Neuropsychopharmacol., 1997; 7 (Suppl. 3): 337-340. Go to original source... Go to PubMed...
    21. Heinz A. Dopaminergic dysfunction in alcoholism and schizofrenia - psychopathological and behavioral correlates. European Psychiatry, 2002; 17, 1: 9-16. Go to original source... Go to PubMed...
    22. Chick J, Howlett H, Morgan MY, Ritson B. United Kingdom multicentre acamprosate study (UKMAS): a 6 month prospective study of acamprosate vs.placebo in preventing relapse after withdrawal from alcohol. Alcohol and Alcoholism, 2000: 35. Go to original source... Go to PubMed...
    23. Childress AR, O´Brien CP. Dopamine receptor partial anonists could address the duality of cocaine craving. Trends in Pharmacological Sciences, 2000; 21, 1: 6-9. Go to original source... Go to PubMed...
    24. Kolibáš E, Novotný V. Farmakologická liečba alkoholovej závislosti v súčasnosti. Psychiatrie, 2000; 4: 168-176.
    25. Koob G, Weiss F. Pharmacology of drug self-administration. Alcohol, 1990; 7: 193-197. Go to original source... Go to PubMed...
    26. Kosten TA, Marby DW, Nestler EJ. Chronic buprenorphine attenuates cocaine condicioned place preference, in Proceedings of the Committee on Problems of Drug Dependence, 1991, L.S.Harris, ed. National Institute on Drug Abuse, Rockville, MD.
    27. Kranzler H, Meyer R. An open trial of buspirone in alcoholics. J.Clin.Psychopharmacol., 1989; 9: 379-380. Go to original source... Go to PubMed...
    28. Kraus M, Gottlieb L, Horowitz R, Anscher M. Randomized clinical trial of atenolol in patients with alcohol withdrawal syndrome, N. Engl. J. Med., 1985; 313: 905-909. Go to original source... Go to PubMed...
    29. Lang PJ, Bradley MM, Cuthberg BN. Emotion, attention, and startle reflex. Psychol Rev, 1990; 97: 377-395. Go to original source... Go to PubMed...
    30. Mannelli P, Mizzoni C, Janiri L, Lombardi U, De Risio S, Tempesta E. Craving for alcohol and dopamine activity. Biological Psychiatry, 1997; 1, 42 (Suppl. 1): 35 S. Go to original source...
    31. Maurel S, De Vry J, Schreiber R. Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol prefering cAA rats. Alcoholism, 1999; 17, 3: 195-201. Go to original source... Go to PubMed...
    32. Mello NK, Mendelson JH, Kuehnle UC. Buprenorphine effects on human heroin self-administration: an operant analysis. J. Pharmacol. Exp. Ther., 1982; 223 (1): 30-39.
    33. Mello NK, Mendelson JH, Bree MB, Lukas SE. Buprenorphine suppresses cocaine self-administration by Rhesus monkeys. Science, 1989; 245: 859-862. Go to original source... Go to PubMed...
    34. Mendelson JH. Comparison of buprenorphine and methadone effects on opiate self-administration in primates. J. Pharmacol. Exp. Ther., 1983; 225 (2): 378-386.
    35. Medzinárodní klasifikace nemocí, 10. revize. Duševní poruchy a poruchy chování. Popisy klinických príznakú a diagnostická vodítka. Praha, 1992: 282.
    36. Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlec K, Sykora K. The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin. Pharmacol. Ther., 1987; 41, 3: 266-274. Go to original source... Go to PubMed...
    37. Naranjo CA, Kadlec K, Sanheuza P, Woodley-Remus DV, Sellers EM. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin.Pharmacol.Ther., 1990; 47, 4: 490-498. Go to original source... Go to PubMed...
    38. Novotný V. Serotonergické mechanizmy alkoholovej závislosti a možnosti ich využitia v terapii. Alkoholizmus a drogové závislosti, 2000; 35, 1: 3-12.
    39. Novotný V, Švestka J. Liečba závislosti od nikotínu bupropionom, Alkoholizmus a drogové závislosti, 2003; 38, 4-5: 255.
    40. Pelchat ML. Food craving, obsession, compulsion, and addiction. Physiology & Behavior, 2002; 76, 3: 347-352. Go to original source... Go to PubMed...
    41. Pilla M. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature, 1999; 400: 371-375. Go to original source... Go to PubMed...
    42. Poldrugo F. Acamprosate treatment in a long-term community-baased alcohol rehabilitation. Addiction, 92, 1997: 1537-1546. Go to original source...
    43. Privette T, Hornsby R, Myers R. Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways. Alcohol, 1988; 5: 147-152. Go to original source... Go to PubMed...
    44. Robbins SJ. Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride. Addict. Behav., 1992; 17: 491-499. Go to original source... Go to PubMed...
    45. Rosten MI, Pearsall HR, McDougle CJ, Price LH, Woods SW, Kosten TR. Effects of acute buprenorphine on responses to intranasal cocaine. Proceedings of the Committee on the Problems of Drug Dependence, 1992, submitted abstract.
    46. Tempesta E, Janiri L, Bignamini A, Chabac S, Potgieter A. Acamprosate and relapse prevention in the treatment of alcohol dependence: A placebo-controlled study. Alcohol and Alcoholism, 2000; 35: 1-8. Go to original source... Go to PubMed...
    47. Teoh SK, Sintavanarong P, Kuehnle J, Mendelson JH, Hallring E, Rhoades E, Mello NK. Buprenorphine effects on morphine and cocaine challenges in heroin and cocain dependent men, in Proceedings of the Committee on Problems of Drug Dependence, 1991, L.S. Harris, ed. National Institute on Drug Abuse, Rockville, MD..
    48. Van den Brink W, de Vos JW. The role pharmacokinetics and psychopathology in the prediction of craving among opiate addicts in methadone maintenance therapy. European Psychiatry, 1996; 11 (Suppl. 4): 235S. Go to original source...
    49. Volpicelli J, O´Brien C, Alterman A, Hayashida M. Naltrexone and the treatment of alcohol-dependence: Initial observations, in Opioids Bulimia, and Alcohol Abuse and Alcoholism, L. Reid, 1990, ed. Springer-Verlag, New York, 195-214.
    50. White JM, Danz C, Kneebone J, La Vincente SF, Newcombe DAL, Ali RL. Relationship between LAAM-methadone preference and treatment outcomes. Drug and Alcohol Dependence, 2002; 66, 3: 295-301. Go to original source... Go to PubMed...
    51. Wilde MI, Wagstaff AJ. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxifikation. Drugs, 1997; 53: 1038-1053. Go to original source... Go to PubMed...
    52. Wise RA. The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 1988; 97: 118-132. Go to original source... Go to PubMed...
    53. Zieglänsberger W, Putzke J, Spanagel R. Glutamatergic brain systems and addiction. European Psychiatry, 1996; 11 (Suppl. 4): 162 S. Go to original source...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.